yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33425130-DFB04874-FF6C-4013-806D-48AF541AC2BA
Q33425130-DFB04874-FF6C-4013-806D-48AF541AC2BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33425130-DFB04874-FF6C-4013-806D-48AF541AC2BA
Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.
P2860
Q33425130-DFB04874-FF6C-4013-806D-48AF541AC2BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33425130-DFB04874-FF6C-4013-806D-48AF541AC2BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5977677db0b2d51a92778d47206f53cd06fa4cd7
P2860
Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.